Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





COVID-19 Vaccines Under Development Not Guaranteed to Work, Warns Merck CEO

By HospiMedica International staff writers
Posted on 16 Jul 2020
COVID-19 vaccines that are currently under development are not guaranteed to work and those claiming that a vaccine would be ready before the year-end are doing a “grave disservice to the public,” according to Kenneth Frazier, Chief Executive of Merck (Kenilworth, NJ, USA).

In an interview published on a Harvard Business School website, Frazier said that the potential COVID-19 vaccines may lack the qualities required for rapid deployment among a large population. More...
“If you’re going to use a vaccine on billions of people, you better know what that vaccine does,” he said.

Frazier’s comments came soon after a US official stated that drugmakers partnering with the US government were on track to begin actively manufacturing a COVID-19 vaccine by summer end. The Trump administration has rolled out Operation Warp Speed Program with a target to produce 300 million vaccine doses by the end of 2021. Merck plans to study potential vaccine and therapy candidates for COVID-19 but has not yet begun clinical trials for its vaccine.

Frazier warned that some previous vaccines “not only didn’t confer protection, but actually helped the virus invade the cell, because it was incomplete in terms of its immunogenic properties. So we have to be very careful.”

Related Links:
Merck


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
New
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.